Quick Answer
AVITA Medical, Inc. reported Total Revenue of $71.61 million for the year ending 2025.
- AVITA Medical, Inc. showed an increase of +11.5% in Total Revenue from 2024 to 2025.
- This data is from AVITA Medical, Inc.'s annual report (Form 10-K), filed with the SEC on February 12, 2026.
- XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2018: $269.0 thousand | Q4 2018: $1.04 million | Q1 2019: $1.71 million | Q2 2019: $2.46 million | Q3 2019: $3.25 million | Q4 2019: $3.26 million | Q1 2020: $3.88 million | Q2 2020: $3.88 million | Q3 2020: $5.06 million | Q4 2020: $5.10 million | Q1 2021: $8.77 million | Q2 2021: $10.30 million | Q3 2021: $7.02 million | Q1 2022: $7.54 million | Q2 2022: $8.34 million | Q3 2022: $9.09 million | Q1 2023: $10.55 million | Q2 2023: $11.75 million | Q3 2023: $13.65 million | Q1 2024: $11.10 million | Q2 2024: $15.20 million | Q3 2024: $19.55 million | Q1 2025: $18.51 million | Q2 2025: $18.42 million | Q3 2025: $17.06 million.
- Over the full 8 years of available data (2018 to 2025), AVITA Medical, Inc.'s Total Revenue has grown by 7,608.3%.
- Historical annual values: Fiscal year 2025: $71.61 million | Fiscal year 2024: $64.25 million | Fiscal year 2023: $50.14 million | Fiscal year 2022: $34.42 million | Fiscal year 2021: $29.23 million | Fiscal year 2020: $14.26 million | Fiscal year 2019: $5.47 million | Fiscal year 2018: $929.0 thousand.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: